StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 9/15/2014, (NASDAQ:SLXP), $143.43 -5.56, -3.73%, "SELL" Salix Pharmaceuti Stock
 




  
  

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   9/15/2014   StockRing.com recommends to   "SELL"   SLXP   stock at current price of   $143.43.
Today SLXP stock opened at $147.03 and was trading in the daily range of $ 143.24 - 148.45 per share.
Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $9.135B. SLXP average daily volume is 1,342,390.
On last trading session SLXP stock traded 1,861,138 shares. Also the Short Ratio for (NASDAQ:SLXP) stock is 9.20.
Last year Salix Pharmaceuti(NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $454.5M on revenue of $1.262B.
SLXP 50-Day Moving Average is $144.87 vs. $143.43 now and 200-Day Moving Average is $121.75 vs. $143.43.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "HOLD".  S&P 500 is "HOLD" on  5/16/2014
--------------------------------------------------------------------------------------------------------------------
SLXP Earnings Per Share - EPS (ttm) is 0.9. SLXP Stock Price Per Earnings ratio - P/E is 164.99.
Salix Pharmaceuti(NASDAQ:SLXP) stock pays a dividend of $0.00 per share which is a yield of N/A%.
On average analysts predict that One Year Target Estimated price for SLXP stock is $158.69.
In the last 52 weeks SLXP stock was trading in the range of $65.38 - 162.38.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

BUY  DOW 30+:    ENERGY: ADMA  RNG  CDW  CBA  BLUE     HEALTH: ACWX  EPHE  FM  DVYA  AOM 
      FINANCE: XLK  DWX  BWZ  GII  SCPB     SERVICES: UST  MLPX  BRAQ  YCL  EMFM     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: GGB     ENERGY: RMAX  SEAS  NBCB  PETX  VOYA     HEALTH: ITA  ICLN  EIRL  SCZ  PICK 
      FINANCE: XME  XSW  KBE  EWO  BAL     SERVICES: VIXM  EEV  UVXY  QID  AGQ     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



9/15/2014  Monday, September 15, 2014 (Irvine, California) Today StockRing.com Recommendation is to "SELL"for Salix Pharmaceuti (NASDAQ:SLXP) Stock. SLXP stock opening price was $147.03 per share. Current price of NASDAQ:SLXP Stock is $143.43 per share and it is $-5.56, (-3.73%) today and it was trading in the daily range of $143.24 - 148.45 per share. Current Bid Price for (NASDAQ:SLXP) stock is $143.43 and the Ask Price is $143.46. In the last 52 weeks SLXP stock was trading in the range of $65.38 - 162.38. 50-Day Moving Average for (NASDAQ:SLXP) stock is $144.87 and 200-Day Moving Average is $121.75. On average analysts predict that One Year Target Estimated price for (NASDAQ:SLXP) stock is $158.69.

Salix Pharmaceuti (NASDAQ:SLXP) is rated as a sell on 9/10/2014 1:26:20 AM.

Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $9.135B. (NASDAQ:SLXP) stock average daily volume is 1,342,390 shares per day. However, on last trading session of Sep 12, 2012 SLXP stock traded 1,861,138 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:SLXP) stock is 9.20. On previous trading session SLXP Stock closed at $148.99 per share.

Last year Salix Pharmaceuti (NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $454.5M on total revenue of $1.262B. Earnings Per Share - EPS (ttm) for SLXP stock is 0.9. Also, (NASDAQ:SLXP) Stock Price Per Earnings ratio - P/E is 164.99. Thus, (NASDAQ:SLXP) Stock Price/Sales (ttm) ratio is 7.52 and Price/Book (mrq) ratio is 12.85.

(NASDAQ:SLXP) Stock does NOT PAY any dividend. So at this time (NASDAQ:SLXP) Stock maintains Trailing Annual Dividend Rate at 0.00 .


StockRing Recommendations for Salix Pharmaceuti (NASDAQ:SLXP) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=SLXP

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:SLXP Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

9/15/2014 1 Year Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Monday, September 15, 2014
  
1 Year SLXP 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
9/15/2014 5 days Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Monday, September 15, 2014
  
5 Days SLXP 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:SLXP Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

9/15/2014 Stock market price quote data for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Monday, September 15, 2014

Last Trade: 143.43
Trade Time: Sep 12
Change: -5.56, (-3.73%)
Prev Close: 148.99
Open: 147.03
Bid: 143.43
Ask: 143.46
1y Target Est: $158.69
50-Day Moving Average: 144.87
200-Day Moving Average:
121.75
Short Ratio: 9.20
Trailing Annual Dividend Rate: 0.00
Day's Range: 143.24 - 148.45
52wk Range: 65.38 - 162.38
Volume: 1,861,138
Avg Vol: 1,342,390
Market Cap: 9.135B
P/E (ttm): 164.99
EPS (ttm): 0.9
Div & Yield: 0.00 (N/A%)
Revenue (ttm): 1.262B
Earnings before Tax (EBITDA) (ttm): 454.5M
Price/Sales (ttm): 7.52
Price/Book (mrq): 12.85
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs



9/15/2014 Latest stock market news data for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Monday, September 15, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

Credit Suisse Sees Downside In Shares Of Salix Pharmaceuticals, Ltd.
Benzinga - Sep 12, 2014
Analysts at Credit Suisse initiated coverage on Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) with an Underperform rating and $139 price target Friday.
Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today
TheStreet.com - Aug 19, 2014
"We rate SALIX PHARMACEUTICALS LTD (SLXP) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover.
Allergan, Seeking to Fend Off Hostile Bid, Approaches Salix - Wall Street Journal
Salix Gains 15.5% After News Of Potential Acquisition By Allergan - Bidness Etc
Salix Pharmaceuticals Larger Than S&P 500 Component Expedia
Forbes - Aug 26, 2014
... capitalization (factoring in those share counts) creates a true “apples-to-apples” comparison of the value of two stocks. In the case of Salix Pharmaceuticals Ltd (NASD: SLXP), the market cap is now $10.04B, versus Expedia Inc (NASD: EXPE) at $10.00B.
Salix Submits Response To FDA's Complete Response Letter Regarding ...
Bidness ETC - Sep 3, 2014
Salix Pharmaceuticals, Ltd. (SLXP) announced yesterday that it has filed a response to the Complete Response Letter (CRL) issued by the US Food and Drug Administration (FDA) on March 7, 2011.
Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan
Zacks.com - Aug 20, 2014
Salix Pharmaceuticals Ltd. (SLXP - Analyst Report) shares surged 15.5% after The Wall Street Journal claimed that Allergan Inc. (AGN - Analyst Report) has approached Salix to acquire it.
Today's Unusual Social Activity Stock: Salix Pharmaceuticals (SLXP)
TheStreet.com - Aug 15, 2014
SALIX PHARMACEUTICALS LTD has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Cognizant Technology Solutions Corp (CTSH), Titan International Inc. (TWI ...
Insider Monkey (blog) - Aug 21, 2014
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) has felt plenty of hedge fund 'bullishness' lately. Over the past week, two funds disclosed increases in their stakes in the company.
Salix Announces Early Termination of HSR Waiting Period for Pending Transaction - MarketWatch
Salix Pharmaceuticals Ltd (NASDAQ:SLXP) Shares Soars on Takeover Bid from ...
iStreetWire - Aug 29, 2014
Shares of Salix Pharmaceuticals Ltd (NASDAQ:SLXP) was in the spotlight recently as a possible axqustion candidate for Allergan (NYSE:AGN), the manufacturer of Botox.
Salix files response to CRL (SLXP)
Seeking Alpha (registration) - Sep 2, 2014
Salix Pharmaceuticals (SLXP +0.5%) submits its response to the March 7, 2011 CRL it received from the FDA regarding its sNDA for Xifaxan (rifaximin) 550 mg tablets for the treatment of irritable bowel syndrome with diarrhea (IBS-D).
Salix Responds To FDA's XIFAXAN 550mg Complete Response Letter - RTT News
Salix Submits Response to XIFAXAN® 550mg Complete Response Letter ... - Business Wire (press release)
Salix Pharmaceuticals Receives New Coverage from Analysts at Credit Suisse ...
sleekmoney - Sep 12, 2014
Salix Pharmaceuticals, Ltd. logo Analysts at Credit Suisse started coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a research report issued to clients and investors on Friday, TheFlyOnTheWall.

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


9/15/2014 News from StockRing Blog about Salix Pharmaceuti (NASDAQ:SLXP) Stock on Monday, September 15, 2014



Copyright © 2014 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds   Form

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.